David A. Siegel Celcuity Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Celcuity Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 21,900 shares of CELC stock, worth $286,890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,900
Previous 51,200
57.23%
Holding current value
$286,890
Previous $670,000
67.01%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CELC
# of Institutions
98Shares Held
30.6MCall Options Held
16.2KPut Options Held
51.9K-
Baker Bros. Advisors LP New York, NY4.26MShares$55.8 Million0.51% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$45.4 Million1.54% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$33.7 Million2.15% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$30.9 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$21.9 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $196M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...